Recruiting Melanoma Studies in Nashville
Study of IDE196 in Patients with Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
This is a Phase 1/2, multi-center, open-label basket study designed to evaluate the safety and anti-tumor activity of IDE196 in patients with solid tumors harboring GNAQ or GNA11 (GNAQ/11) mutations o...
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
A Phase 1/2, open-label study of a modified interleukin-2 fusion protein (IOV 3001) in participants with previously treated, unresectable or metastatic melanoma who will receive lifileucel....
About Melanoma Clinical Trials in Nashville
Melanoma is the most serious type of skin cancer, developing from the pigment-producing cells known as melanocytes. While less common than other skin cancers, melanoma is more likely to spread. Immunotherapy and targeted therapy have revolutionized melanoma treatment.
There are currently 2 melanoma clinical trials recruiting participants in Nashville, TENNESSEE. These studies are seeking a combined 383 participants. Research is being sponsored by IDEAYA Biosciences, Iovance Biotherapeutics, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Melanoma Clinical Trials in Nashville — FAQ
Are there melanoma clinical trials in Nashville?
Yes, there are 2 melanoma clinical trials currently recruiting in Nashville, TENNESSEE. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Nashville?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Nashville research site will contact you about next steps.
Are clinical trials in Nashville free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Nashville studies also compensate for your time and travel.
What melanoma treatments are being tested?
The 2 active trials in Nashville are testing new therapies including novel drugs, biologics, and treatment approaches for melanoma.
Data updated March 2, 2026 from ClinicalTrials.gov